Jehan Faisal, Brady Maureen, Attwood Kristopher, Hochwald Steven N, Kukar Moshim
Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, United States.
Division of Surgical Oncology, Mount Sinai Medical Center, Miami Beach, FL, United States.
J Gastrointest Surg. 2025 Apr;29(4):101979. doi: 10.1016/j.gassur.2025.101979. Epub 2025 Jan 29.
With published randomized data, minimally invasive esophagectomy (MIE) has become increasingly popular. However, substantial variability in techniques and outcomes still exists.
This was a retrospective analysis of 150 consecutive robotic-assisted MIEs (RAMIEs) from a prospectively maintained database from 2020 to 2024 at a single comprehensive cancer center. This study aimed to evaluate the textbook outcome rates after RAMIE.
A total of 150 consecutive patients underwent RAMIE from 2020 to 2024. Tumor location included the esophagus in 18 patients, type 1 gastroesophageal junction (GEJ) in 52 patients, type 2 GEJ in 71 patients, and type 3 GEJ in 9 patients. Most patients had clinical stage T3 tumors. Neoadjuvant therapy was used in 85% of the patients. A complete pathologic response was observed in 27% of patients. The median number of lymph nodes retrieved was 21. Anastomotic leak occurred in 2 patients, none of whom required reoperation. The median hospital stay duration was 7 days. The 30- and 90-day mortality rates were 0.7% and 1.3%, respectively. In addition, the 90-day stricture rate after endoscopic dilation was 0.7%. Of note, 90% of patients had a textbook outcome.
This single-center experience highlights that the combination of a robotic platform and a side-to-side stapled anastomotic technique helps achieve exceptional postoperative outcomes for MIE, with a textbook outcome rate of 90%. With the increasing worldwide adoption of MIE, this seems to be an appropriate time to standardize operative techniques to optimize postoperative outcomes.
随着随机数据的发表,微创食管切除术(MIE)越来越受欢迎。然而,技术和结果仍存在很大差异。
这是一项回顾性分析,对2020年至2024年在单个综合癌症中心前瞻性维护的数据库中连续150例机器人辅助MIE(RAMIE)进行分析。本研究旨在评估RAMIE后的教科书式结局率。
2020年至2024年共有150例连续患者接受了RAMIE。肿瘤位置包括食管18例,1型胃食管交界(GEJ)52例,2型GEJ 71例,3型GEJ 9例。大多数患者患有临床T3期肿瘤。85%的患者接受了新辅助治疗。27%的患者观察到完全病理缓解。中位淋巴结切除数为21个。2例患者发生吻合口漏,均无需再次手术。中位住院时间为7天。30天和90天死亡率分别为0.7%和1.3%。此外,内镜扩张后90天狭窄率为0.7%。值得注意的是,90%的患者有教科书式结局。
这一单中心经验表明,机器人平台和侧侧吻合技术的结合有助于实现MIE出色的术后结局,教科书式结局率为90%。随着MIE在全球范围内的应用日益增加,现在似乎是规范手术技术以优化术后结局的适当时机。